NDC 79481-0168-01 - meijer LOW DOSE Aspirin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 79481-0168
- Requested NDC
- 79481-0168-01
- Package NDCs from labels
- 79481-0168-1, 79481-0168-2, 79481-0168-3, 79481-0168-4, 79481-0168-5, 79481-0168-6, 79481-0168-7, 79481-0168-01
- Manufacturer
- Meijer, Inc.
- Effective date
- 2024-09-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| meijer LOW DOSE Aspirin | Meijer, Inc. | 2024-09-24 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 79481-0168-1 | meijer LOW DOSE Aspirin | 120 in 1 BOTTLE | TABLET, COATED | 120 | 2 | |
| 79481-0168-1 | meijer LOW DOSE Aspirin | 1 in 1 CARTON | TABLET, COATED | 1 | 2 | |
| 79481-0168-2 | meijer LOW DOSE Aspirin | 1 in 1 CARTON | TABLET, COATED | 1 | 2 | |
| 79481-0168-2 | meijer LOW DOSE Aspirin | 200 in 1 BOTTLE | TABLET, COATED | 200 | 2 | |
| 79481-0168-3 | meijer LOW DOSE Aspirin | 32 in 1 BOTTLE | TABLET, COATED | 32 | 2 | |
| 79481-0168-3 | meijer LOW DOSE Aspirin | 1 in 1 CARTON | TABLET, COATED | 1 | 2 | |
| 79481-0168-4 | meijer LOW DOSE Aspirin | 300 in 1 BOTTLE | TABLET, COATED | 300 | 2 | |
| 79481-0168-5 | meijer LOW DOSE Aspirin | 500 in 1 BOTTLE | TABLET, COATED | 500 | 2 | |
| 79481-0168-6 | meijer LOW DOSE Aspirin | 365 in 1 BOTTLE | TABLET, COATED | 365 | 2 | |
| 79481-0168-7 | meijer LOW DOSE Aspirin | 2 in 1 CARTON | TABLET, COATED | 2 | 2 | |
| 79481-0168-7 | meijer LOW DOSE Aspirin | 365 in 1 BOTTLE | TABLET, COATED | 365 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 79481-0168 | MEIJER LOW DOSE ASPIRIN (ASPIRIN) TABLET, COATED [MEIJER, INC.] | 2 | Current NDC, 11 package rows | 20240927_1bf12831-5d50-c1b4-e063-6394a90a6970.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER MINI 21W | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 43c59de6-8eb2-d00a-e063-6294a90a0b04 | 2025-11-17 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER MINI 24W | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 43c5bd02-62e0-019a-e063-6294a90adcf3 | 2025-11-17 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER MINI 23W | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 43c5d54e-119c-0c6d-e063-6394a90aba4c | 2025-11-17 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER MINI 25N | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 43c5eb1c-b268-acfb-e063-6394a90ad4cc | 2025-11-17 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER MINI 27C | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 43c6157a-4b62-8279-e063-6294a90abe05 | 2025-11-17 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER MINI 27W | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 43c6252f-56b8-9e3c-e063-6294a90aa12c | 2025-11-17 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER MINI 28N | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 43c62e80-9ace-c1f2-e063-6294a90a5bfa | 2025-11-17 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER MINI 29W | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 43c6864c-bc8e-e900-e063-6294a90a7a14 | 2025-11-17 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER MINI 31N | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 43c77b48-18fb-3efe-e063-6294a90ade4b | 2025-11-17 | Warnings | 15FIX9V2JP |
| AGE20S SIGNATURE ESSENCE PACT INTENSE COVER MINI 33N | OCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE | Aekyung Industrial Co., Ltd. | 43c784ce-3a54-5416-e063-6294a90ac9a2 | 2025-11-17 | Warnings | 15FIX9V2JP |
| MIDOL COMPLETE | ACETAMINOPHEN, CAFFEINE, AND PYRILAMINE MALEATE | R J General Corporation | 0c09a178-1a07-4079-b4a6-d1657cb8e714 | 2025-11-17 | Warnings | M013 |
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | R J General Corporation | dbb0d067-71f0-45e4-bc98-548cf4a90b3a | 2025-11-17 | Warnings | M013 R16CO5Y76E |
| MOTRIN IB | IBUPROFEN | R J General Corporation | afa87bb5-7fcb-4ccd-acac-f7931242181f | 2025-11-17 | Warnings | M013 |
| TYLENOL EXTRA STRENGTH | ACETAMINOPHEN | R J General Corporation | 99e45e83-37a3-44df-9a2a-98ba7457a5bb | 2025-11-17 | Warnings | M013 |
| TYLENOL PM EXTRA STRENGTH | ACETAMINOPHEN | R J General Corporation | a40ea0e3-d666-4605-b5e0-beeaf8f586f2 | 2025-11-17 | Warnings | M013 |
| Acetaminophen 250 mg and Ibuprofen 125 mg | ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG | R J General Corporation | 68d3be55-9340-4cc9-a05a-12b9338ddc56 | 2025-11-17 | Warnings | M013 |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | dd9aaf80-6c2b-41a3-87b9-61642aaed4f0 | 2025-11-17 | Warnings | M013 |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | 1c18a2da-1718-4c00-aea8-9fb4a3418312 | 2025-11-17 | Warnings | M013 |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | cd3060a5-3b90-42e4-89cd-3b620859045f | 2025-11-17 | Warnings | M013 |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | 1c7221ae-52d1-4d18-b586-c47ff656150d | 2025-11-17 | Warnings | M013 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.